SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?
16 references·1 citing·43 second hop
Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter? (2013)Estimating the willingness to pay for a q…QALYs: The Basics (2009)QALYs: The BasicsQALYs: Some Challenges (2009)QALYs: Some ChallengesInternational survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? (2009)International survey on willi…Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold (2008)Assessing cost-effectiveness …Willingness to Pay for a Quality-Adjusted Life Year: Implications for Societal Health Care Resource Allocation (2005)Willingness to Pay for a Qual…Willingness to pay for a QALY (2003)Willingness to pay for a QALYWhat Is the Price of Life and Why Doesn't It Increase at the Rate of Inflation? (2003)What Is the Price of Life and…Is there a kink in consumers' threshold value for cost‐effectiveness in health care? (2002)Is there a kink in consumers'…Willingness to Pay for a Quality-adjusted Life Year (2000)Willingness to Pay for a Qual…Cost-Value Analysis in Health Care (1999)Cost-Value Analysis in Health…Cost value analysis in health care making sense out of QALYs (1999)Cost value analysis in health…Outcome measurement in economic evaluation (1996)Outcome measurement in econom…Valuing health care: costs, benefits, and effectiveness of pharmaceuticals and other medical technologies (1995)Valuing health care: costs, b…Valuing Health Care (1995)Valuing Health CareProspect theory: An analysis of decision under risk (1988)Prospect theory: An analysis …Prospect Theory: An Analysis of Decision under Risk (1979)Prospect Theory: An Analysis …The use of economic evaluation for guiding the pharmaceutical reimbursement list in Thailand (2014)The use of economic evaluatio…A utility maximization model for evaluation of health care programs. (1972)Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Making Descriptive Use of Prospect Theory to Improve the Prescriptive Use of Expected Utility (2001)Conceptualizing a Model (2012)Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries (2017)Assetization (2020)Contingent Valuation: Is Some Number Better than No Number? (1994)Cost-Effectiveness in Health and Medicine (1996)Cost-of-illness studies: concepts, scopes, and methods (2014)Thresholds for the cost–effectiveness of interventions: alternative approaches (2014)Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold (2015)Social Security Bulletin (2018)Protected Values and Omission Bias (1999)Interpreting the Results of Cost-Effectiveness Studies (2008)What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule? (2008)A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors (2018)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)The MOS 36-ltem Short-Form Health Survey (SF-36) (1992)A 12-Item Short-Form Health Survey (1996)Cognitive impairment and preferences for current health (2009)Cost Effectiveness in Low- and Middle-Income Countries (2009)Technology Diffusion and Productivity Growth in Health Care (2015)Measurement of health state utilities for economic appraisal (1986)The Value of a Statistical Life: A Critical Review of Market Estimates Throughout the World (2003)Methods for the Economic Evaluation of Health Care Programmes (2005)Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review (2010)Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting (2011)On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review (2018)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Recommendations for Reporting Cost-effectiveness Analyses (1996)Productivity Costs in Economic Evaluations: Past, Present, Future (2013)The Willingness to Pay for a Quality Adjusted Life Year: A Review of the Empirical Literature (2014)Risk, Ambiguity, and the Savage Axioms (1961)Judgment under Uncertainty: Heuristics and Biases (1975)The Framing of Decisions and the Psychology of Choice (1981)Exploration and Exploitation in Organizational Learning (1991)Explicating dynamic capabilities: the nature and microfoundations of (sustainable) enterprise performance (2007)Theory of games and economic behavior (2019)The role of adaptation to disability and disease in health state valuation: a preliminary normative analysis (2002)Comparison of direct and indirect methods of estimating health state utilities for resource allocation: review and empirical analysis (2009)Explicit incorporation of equity considerations into economic evaluation of public health interventions (2009)Public healthcare resource allocation and the Rule of Rescue (2008)Advances in prospect theory: Cumulative representation of uncertainty (1992)
this work references cited by second hop

References

  • 1979Prospect Theory: An Analysis of Decision under Risk48,459 cited
  • 1988Prospect theory: An analysis of decision under risk32,475 cited
  • 2000Willingness to Pay for a Quality-adjusted Life Year849 cited
  • 2009QALYs: The Basics757 cited
  • 2009International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?692 cited
  • 2008Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold637 cited
  • 2003What Is the Price of Life and Why Doesn't It Increase at the Rate of Inflation?588 cited
  • 1999Cost-Value Analysis in Health Care272 cited
  • 1999Cost value analysis in health care making sense out of QALYs224 cited
  • 2005Willingness to Pay for a Quality-Adjusted Life Year: Implications for Societal Health Care Resource Allocation219 cited
  • 1995Valuing Health Care211 cited
  • 2009QALYs: Some Challenges187 cited
  • 1996Outcome measurement in economic evaluation167 cited
  • 2003Willingness to pay for a QALY161 cited
  • 2002Is there a kink in consumers' threshold value for cost‐effectiveness in health care?151 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

1995
Valuing health care: costs, benefits, and effectiveness of pharmaceuticals and other medical technologies
140 cited

Cited by

  • 2014The use of economic evaluation for guiding the pharmaceutical reimbursement list in Thailand90 cited